laurocapram has been researched along with sumatriptan in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balaguer-Fernández, C; Femenía-Font, A; López-Castellano, A; Merino, V | 1 |
Balaguer-Fernández, C; Del Rio-Sancho, S; Femenía-Font, A; López-Castellano, A; Merino, V | 1 |
Balaguer-Fernández, C; Femenía-Font, A; López-Castellano, A; Merino, V; Padula, C; Santi, P | 1 |
3 other study(ies) available for laurocapram and sumatriptan
Article | Year |
---|---|
Combination strategies for enhancing transdermal absorption of sumatriptan through skin.
Topics: Adjuvants, Pharmaceutic; Administration, Cutaneous; Animals; Azepines; Cyclohexenes; Ethanol; Humans; In Vitro Techniques; Iontophoresis; Limonene; Polyethylene Glycols; Serotonin Receptor Agonists; Skin; Skin Absorption; Sumatriptan; Sus scrofa; Terpenes | 2006 |
Sumatriptan succinate transdermal delivery systems for the treatment of migraine.
Topics: Administration, Cutaneous; Animals; Azepines; Chemistry, Pharmaceutical; Diffusion Chambers, Culture; Drug Carriers; Drug Compounding; Iontophoresis; Kinetics; Methylcellulose; Migraine Disorders; Permeability; Plasticizers; Polymers; Polymethacrylic Acids; Polyvinyl Alcohol; Povidone; Propylene Glycol; Serotonin Receptor Agonists; Skin; Skin Absorption; Sorbitol; Sumatriptan; Swine; Technology, Pharmaceutical; Tissue Adhesives; Vasoconstrictor Agents | 2008 |
Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate.
Topics: Administration, Cutaneous; Antihypertensive Agents; Azepines; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Interactions; Drug Stability; Hydrogen-Ion Concentration; Migraine Disorders; Permeability; Polyvinyl Alcohol; Polyvinyls; Serotonin Receptor Agonists; Skin Absorption; Solubility; Sumatriptan; Technology, Pharmaceutical; Vasoconstrictor Agents | 2010 |